Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2013
04/10/2013EP2575866A1 Inhibitors of hcv ns5a
04/10/2013CN202860256U Filter and TGIC (Triglycidyl Isocyanurate) synthesis production system adopting filter
04/10/2013CN103038218A Condensed ring pyridine compound
04/10/2013CN103038214A Process of producing cycloalkylcarboxamido-indole compounds
04/10/2013CN103037860A Pyrrolidine Substituted Flavones For The Treatment Of Inflammatory Disorders
04/10/2013CN103037694A Noxious arthropod control composition, and heterocyclic compound
04/10/2013CN103030633A Process and intermediate compounds useful in the preparation of statins
04/10/2013CN103030632A Heterocyclic compound, light-emitting element, light-emitting device, electronic device, and lighting device
04/10/2013CN103030617A Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture
04/10/2013CN103030585A Heterocyclic compound, organic light-emitting diode and flat panel display device
04/10/2013CN102321074B Indole ring-substituted pyrazole hydrazide derivative and preparation method and application thereof
04/10/2013CN101528723B Renin inhibitors
04/09/2013US8415387 Modulators of ATP-binding cassette transporters
04/09/2013US8415382 Substituted benzazoles and methods of their use as inhibitors of RAF Kinase
04/09/2013US8415378 Isoxazol-3(2H)-one analogs as therapeutic agents
04/09/2013US8415348 Nitrogenated derivatives of pancratistatin
04/09/2013CA2704986C Use of an ionic compound, derived from malononitrile as a photoinitiator, radical initiators or catalyser in polymerization processes or as a basic dye
04/09/2013CA2659590C Irreversible protein tyrosine kinases inhibitors and the preparation methods and uses thereof
04/09/2013CA2572833C Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
04/09/2013CA2561555C Bicyclic aromatic sulfinyl derivatives
04/09/2013CA2531050C Pharmaceutical compounds
04/09/2013CA2527192C Novel imidazole derivatives, the production thereof, and the use of the same as a medicament
04/04/2013WO2013049686A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
04/04/2013WO2013049559A1 Pyridine derivatives
04/04/2013WO2013049096A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
04/04/2013WO2013048982A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
04/04/2013WO2013048928A1 Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
04/04/2013WO2013047904A1 Amide compound and use thereof for controlling harmful arthropods
04/04/2013WO2013047813A1 1,2,4-triazine-6-carboxamide derivative
04/04/2013WO2013047701A1 Phenyl derivative
04/04/2013WO2013046635A1 Material for organic electroluminescent element, and organic electroluminescent element produced using same
04/04/2013WO2013045516A1 Viral replication inhibitors
04/04/2013WO2012178100A3 Di-isoimide compounds,compositions, and preparation thereof
04/04/2013US20130085164 Imidazole Derivatives
04/04/2013US20130085158 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
04/04/2013US20130085132 Pyrazole compound and pharmaceutical use thereof
04/04/2013US20130085127 Heterocyclic compound and h1 receptor antagonist
04/04/2013DE4432732B4 3-Aryl-benzofuranone als Stabilisatoren 3-aryl-benzofuranones as stabilizers
04/04/2013DE112011101447T5 Bicarbazol enthaltende Verbindungen für OLEDs Bicarbazol containing compounds for OLEDs
04/04/2013CA2850551A1 Pyridine derivatives
04/04/2013CA2850367A1 Uridine diphosphate derivatives, compositions and methods for treating neurodegenerative disorders
04/04/2013CA2849000A1 Phenyl derivative
04/04/2013CA2848604A1 Viral replication inhibitors
04/03/2013EP2574193A2 Thiol detection
04/03/2013CN103025727A Process For The Preparation Of HMG-COA reductase inhibitors and intermediates thereof
04/03/2013CN103025725A Hetero ring compound
04/03/2013CN103025714A Flufenoxine derivatives for the treatment and prevention of amiloyd pathologies
04/03/2013CN103025383A Compounds for the treatment of clostridium difficile associated disease
04/03/2013CN103012397A Pyrazolo quinolinone derivative and preparation method thereof as well as therapeutic application of derivative
04/03/2013CN103012383A Ezetimibe intermediate and preparation method and application thereof
04/03/2013CN103012382A Method for preparing olmesartan medoxomil
04/03/2013CN103012381A Benzofuran compound, preparation method thereof and application of benzofuran compound in preparation of antiarrhythmic drugs
04/03/2013CN103012380A Chroman compound, and preparation method and application thereof
04/03/2013CN103012378A 3-phenyl-pyrazole derivatives as modulators of the 5-HT2a serotonin receptor useful for the treatment of disorders related thereto
04/03/2013CN103012376A Amide derivatives
04/03/2013CN103012337A Synthetic technology for 4-acetamido-2,3-dihydrobenzofuran-7-methyl formate
04/03/2013CN103012261A Method for preparing montelukast sodium and intermediate of montelukast sodium
04/03/2013CN103012238A Preparation method of N-substituted-1H-pyrrole
04/03/2013CN102079726B Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound
04/03/2013CN101684079B Insecticide for agricultural or horticultural use and method of use thereof
04/02/2013US8410266 2,4-pyrimidinediamine compounds and their uses
04/02/2013US8410160 5-membered heterocycle-based P38 kinase inhibitors
04/02/2013US8410138 Compounds for activating TGF-beta signaling
04/02/2013US8410110 9-(piperazinylalkyl) carbazoles as Bax-modulators
04/02/2013US8410093 Cycloalkyl substituted pyrimidinediamine compounds and their uses
04/02/2013US8410045 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same
04/02/2013CA2642130C Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
04/02/2013CA2564085C Heterocyclic amide compound and use thereof as an mmp-13 inhibitor
03/2013
03/28/2013WO2013042800A1 Chromene compound and curable composition
03/28/2013WO2013042775A1 Aromatic amine derivative and organic electroluminescence element using same
03/28/2013WO2013042668A1 Radioactive fluorine labeled compound
03/28/2013WO2013042460A1 Organic electroluminescent element, lighting device and display device
03/28/2013WO2013042124A1 Use of strigolactones and strigolactone analogs for treating proliferative conditions
03/28/2013WO2013041602A1 Use of 4-substituted 1-phenyl-pyrazole-3-carboxylic-acid derivatives as agents against abiotic plant stress
03/28/2013WO2013041461A1 Fsh receptor antagonists
03/28/2013WO2013041457A1 N-piperidin-4-yl derivatives
03/28/2013WO2013041176A1 Carbazole derivatives for organic electroluminescence devices
03/28/2013WO2013041042A1 Pyrazole carboxamides as janus kinase inhibitors
03/28/2013WO2013016193A3 Activators of class i histone deacetlyases (hdacs) and uses thereof
03/28/2013WO2012172562A3 Hybrid molecules containing pharmacophores of fluconazole as antifungal agents and their preparation
03/28/2013WO2012136873A8 Triazine derivatives and their uses as trpv1 inhibitors
03/28/2013WO2011006935A3 Tetrazole derivatives
03/28/2013US20130079373 Substituted Methanesulfonamide Derivatives as Vanilloid Receptor Ligands
03/28/2013US20130079361 Novel iodo pyrimidine derivatives useful for the treatment of macrophage migration inhibitory factor (mif)-implicated diseases and conditions
03/28/2013US20130079345 Pharmaceutically active disubstituted triazine derivatives
03/28/2013US20130079339 Trpv1 vanilloid receptor antagonists with a bicyclic portion
03/28/2013US20130079329 INDAZOLE-3-CARBOXAMIDES AND THEIR USE AS WNT/Beta-CATENIN SIGNALING PATHWAY INHIBITORS
03/28/2013US20130079326 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
03/28/2013US20130079303 Inhibitors of PI3 Kinase and/or mTOR
03/28/2013US20130079302 N-[(het)arylalkyl)] pyrazole(thio)carboxamides and their heterosubstituted analogues
03/28/2013US20130074927 Highly-fluorescent and photo-stable chromophores for enhanced solar harvesting efficiency
03/28/2013CA2849343A1 Use of strigolactones and strigolactone analogs for treating proliferative conditions
03/28/2013CA2849282A1 Chromene compound and curable composition
03/28/2013CA2849278A1 Radioactive fluorine-labeled compound
03/28/2013CA2849176A1 Fsh receptor antagonists
03/28/2013CA2849169A1 Pyrazole carboxamides as janus kinase inhibitors
03/28/2013CA2849109A1 N-piperidin-4-yl derivatives
03/28/2013CA2849087A1 Carbazole derivatives for organic electroluminescent devices
03/27/2013EP2573080A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
03/27/2013EP2573079A2 Benzimidazole quinolinones and uses thereof
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 694